TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno...
Read More
Author: PharmaTimes
Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the...
Read More
4 ways AI is shaping the future of Life Sciences
There’s no denying it; pharma is in its innovation era. The life sciences industry is already...
Read More
Acelyrin’s izokibep for hidradenitis suppurativa reveals positive results
However the company will not continue developing the candidate
Read More
myTomorrows and Pancreatic Cancer Europe partner on clinical trials
The partnership will improve care for patients with pancreatic cancer
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
